Literature DB >> 10523217

Baseline IgG antibody titers to Chlamydia pneumoniae, Helicobacter pylori, herpes simplex virus, and cytomegalovirus and the risk for cardiovascular disease in women.

P M Ridker1, C H Hennekens, J E Buring, R Kundsin, J Shih.   

Abstract

BACKGROUND: Results of cross-sectional and retrospective studies have suggested that chronic infection may be a risk factor for cardiovascular disease. However, prospective data evaluating the relation between baseline antibody titers against various plausible agents and risk for cardiovascular disease are sparse, particularly among women.
OBJECTIVE: To determine whether previous exposure to Chlamydia pneumoniae, Helicobacter pylori, herpes simplex virus, or cytomegalovirus is associated with increased risk for cardiovascular events.
DESIGN: Prospective, nested, case-control study.
SETTING: Women's Health Study. PARTICIPANTS: Apparently healthy postmenopausal women. MEASUREMENTS: IgG antibody titers against C. pneumoniae, H. pylori, herpes simplex virus, and cytomegalovirus were measured in baseline blood samples obtained from 122 study participants who subsequently reported a first cardiovascular event (case-patients) and 244 participants matched for age and smoking status who did not report a cardiovascular event (controls) during 3 years of follow-up.
RESULTS: Little evidence was found of an association between risk for cardiovascular events and baseline IgG seropositivity for antibodies against C. pneumoniae (rate ratio, 1.1 [95% CI, 0.7 to 1.8]), H. pylori (rate ratio, 0.90 [CI, 0.6 to 1.4]), herpes simplex virus (rate ratio, 1.2 [CI, 0.6 to 2.1]), and cytomegalovirus (rate ratio, 0.9 [CI, 0.6 to 1.5]). In addition, there was little evidence of an association between a participant's total number of infections and subsequent cardiovascular risk (P > 0.2).
CONCLUSION: In apparently healthy postmenopausal women, little evidence was found that previous infection, as measured by IgG antibody titers to C. pneumoniae, H. pylori, herpes simplex virus, and cytomegalovirus, is associated with subsequent risk for cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10523217     DOI: 10.7326/0003-4819-131-8-199910190-00004

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  26 in total

1.  Circulating nucleic acids of Chlamydia pneumoniae and cytomegalovirus in patients undergoing coronary angiography.

Authors:  M Smieja; S Chong; M Natarajan; A Petrich; L Rainen; J B Mahony
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

Review 2.  Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies.

Authors:  Jens Boman; Margaret R Hammerschlag
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

Review 3.  The role of infection in the genesis and complications of atherosclerosis.

Authors:  Joseph S Alpert
Journal:  Curr Cardiol Rep       Date:  2002-05       Impact factor: 2.931

4.  The incidence of infectious diseases and changes in the mortality of atherosclerosis-related complications in the Czech population over the past two decades.

Authors:  Alena Dvorakova; Rudolf Poledne
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

5.  Chlamydia pneumoniae serology: importance of methodology in patients with coronary heart disease and healthy individuals.

Authors:  A Schumacher; A B Lerkerød; I Seljeflot; L Sommervoll; I Holme; J E Otterstad; H Arnesen
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

6.  Toxic epidermal necrolysis induced by a triple-drug regimen for helicobacter pylori eradication.

Authors:  Yoshihiro Matsukawa; Hiroyuki Hara; Masanori Aoki; Kentaro Inada; Motohide Kaneko; Ko Mitamura; Umihiko Sawada; Shigemasa Sawada; Takashi Horie; Toyoko Ochiai
Journal:  Clin Drug Investig       Date:  2004       Impact factor: 2.859

Review 7.  Chronic infections and atherosclerosis/thrombosis.

Authors:  Prediman K Shah
Journal:  Curr Atheroscler Rep       Date:  2002-03       Impact factor: 5.113

8.  Individual pathogens, pathogen burden and markers of subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Moyses Szklo; Jingzhong Ding; Michael Y Tsai; Mary Cushman; Joseph F Polak; João Lima; R Graham Barr; A Richey Sharrett
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2009-10       Impact factor: 2.160

9.  The influence of persistent pathogens on circulating levels of inflammatory markers: a cross-sectional analysis from the Multi-Ethnic Study of Atherosclerosis.

Authors:  Aydin Nazmi; Ana V Diez-Roux; Nancy S Jenny; Michael Y Tsai; Moyses Szklo; Allison E Aiello
Journal:  BMC Public Health       Date:  2010-11-17       Impact factor: 3.295

10.  Herpesvirus Infections and Risk of Frailty and Mortality in Older Women: Women's Health and Aging Studies.

Authors:  George C Wang; Christina Han; Barbara Detrick; Vincenzo Casolaro; David M Levine; Linda P Fried; Jeremy D Walston
Journal:  J Am Geriatr Soc       Date:  2016-04-30       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.